Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1618
This examiner grants 23% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17795143 | FLUORESCENT SILICA NANOPARTICLES AND METHOD FOR MANUFACTURING FLUORESCENT SILICA NANOPARTICLES | Non-Final OA | Konica Minolta, Inc. |
| 17908766 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | Final Rejection | Emory University |
| 19376049 | COMPOSITIONS AND METHODS FOR NUTRACEUTICAL GUMMY | Final Rejection | NOON WORLD INC. |
| 17906508 | DEUTERIUM MAGNETIC RESONANCE IMAGING | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18177430 | TRANSGLUTAMINASE CONJUGATION METHOD WITH AMINO ACID-BASED LINKERS | Non-Final OA | ARARIS BIOTECH AG |
| 18166390 | METHODS AND COMPOSITION FOR DYE-BASED ENCODING AND QUANTIFICATION | Final Rejection | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 19171160 | LIPID NANOPARTICLES FOR THE TREATMENT OF VASCULAR DISEASES | Non-Final OA | The General Hospital Corporation |
| 17403157 | COSMETIC COMPOSITIONS | Final Rejection | L'Oreal |
| 18424697 | STEREOCOMPLEX OF OLIGOLACTIC ACID CONJUGATES IN MICELLES FOR IMPROVED PHYSICAL STABILITY AND ENHANCED ANTITUMOR EFFICACY | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18445604 | Formulated and/or Co-Formulated Liposome Compositions Containing Toll-Like Receptor ("TLR") Agonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof C | Final Rejection | Nammi Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy